T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Spectrum Brands
SPB
$2.07B
| $19.7M | ﹤0.01% |
165,016
+304
| +0.2% | +$34.9K |
|
1102
Commerce Bancshares
CBSH
$8.6B
| $19.6M | ﹤0.01% |
665,724
-314,980
| -32% | -$9.09M |
|
1103
Crocs
CROX
$6.33B
| $19.6M | ﹤0.01% |
1,733,660
+95,120
| +6% | +$922K |
|
|
VWR
1104
DELISTED
VWR Corporation
VWR
| $19.4M | ﹤0.01% |
672,894
+35,079
| +5% | +$984K |
|
1105
Citizens Financial Group
CFG
$31.2B
| $19.4M | ﹤0.01% |
970,600
+11,700
| +1% | +$260K |
|
1106
Oneok
OKE
$58.7B
| $19.3M | ﹤0.01% |
407,290
+24,120
| +6% | +$957K |
|
1107
U-Haul Holding Co
UHAL
$14.6B
| $19.3M | ﹤0.01% |
515,440
-19,810
| -4% | -$716K |
|
1108
MaxLinear
MXL
$7.02B
| $19.3M | ﹤0.01% |
1,073,395
+460
| +0% | +$8.54K |
|
1109
Chemed
CHE
$7.1B
| $19.3M | ﹤0.01% |
141,250
+5,900
| +4% | +$783K |
|
|
ECOL
1110
DELISTED
US Ecology, Inc.
ECOL
| $19.2M | ﹤0.01% |
418,140
+14,500
| +4% | +$643K |
|
1111
Utah Medical Products
UTMD
$228M
| $19.2M | ﹤0.01% |
304,800
+600
| +0.2% | +$38.7K |
|
1112
UDR
UDR
$12.1B
| $19.2M | ﹤0.01% |
519,554
-2,400
| -0.5% | -$86K |
|
|
CMD
1113
DELISTED
Cantel Medical Corporation
CMD
| $19M | ﹤0.01% |
276,112
+17,922
| +7% | +$1.24M |
|
1114
D.R. Horton
DHI
$41.5B
| $18.7M | ﹤0.01% |
595,220
+7,590
| +1% | +$232K |
|
1115
STRATTEC Security
STRT
$339M
| $18.7M | ﹤0.01% |
458,863
+400
| +0.1% | +$20K |
|
1116
Howard Hughes
HHH
$4.02B
| $18.7M | ﹤0.01% |
171,179
+97,638
| +133% | +$10M |
|
|
CATM
1117
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $18.6M | ﹤0.01% |
467,964
+30,800
| +7% | +$1.18M |
|
|
LL
1118
DELISTED
LL Flooring Holdings, Inc.
LL
| $18.6M | ﹤0.01% |
1,205,318
-148,482
| -11% | -$2.06M |
|
|
MGP
1119
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $18.6M | ﹤0.01% |
+695,577
| New | +$16.5M |
|
1120
Expro Ltd
XPRO
$2.06B
| $18.5M | ﹤0.01% |
+211,523
| New | +$20.1M |
|
1121
Ares Capital
ARCC
$14.4B
| $18.5M | ﹤0.01% |
1,304,500
+18,600
| +1% | +$276K |
|
1122
Eastman Chemical
EMN
$8.37B
| $18.5M | ﹤0.01% |
272,079
-1,658
| -0.6% | -$122K |
|
1123
Hormel Foods
HRL
$13.5B
| $18.4M | ﹤0.01% |
503,656
+13,080
| +3% | +$489K |
|
1124
MGIC Investment
MTG
$6.29B
| $18.3M | ﹤0.01% |
3,077,869
+16,420
| +0.5% | +$112K |
|
|
SFE
1125
DELISTED
Safeguard Scientifics, Inc.
SFE
| $18.3M | ﹤0.01% |
1,464,901
-3,789
| -0.3% | -$50.8K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.